Total sales of drug producer Biofarm increased in the first quarter of the year by 3.3 percent, in units, compared with the same interval last year, with the domestic pharmaceutical market having recorded a drop by more than 6 percent, according to data released by the company.
In terms of value, Biofarm SA increased by 16.1 percent in the first quarter of the year, compared with the same interval in 2007.
The local pharmaceutical market recorded a drop by 6.96 percent from this viewpoint.
The evolution of SC Biofarm SA was mainly due to the development and efficiency strategies implemented by Biofarm SA, the quality-price ratio, as well as such investments made in promotion.
The company injected important amounts in the promotion campaigns of its products in the first quarter of the year, with such amounts exceeding by 65 percent such investments in promotion in the first quarter of 2007, with the profitability rate having been hit thus of approx. 26 percent and an operational profit (EBIDTA) standing at 35 percent.
SC Biofarm SA is one of the important producers of drugs and nutrients in Romania, with an experience of more than 8 decades. The company has a GMP certification for all the production lines, with its shares being listed on the Bucharest Stock Exchange. SC Biofarm SA has more than 70 products in its portfolio.